Skip to main content

Reflux Testing Products Market Size Worth USD 4.56 Billion in 2032 | Emergen Research

Rising prevalence of Gastroesophageal Reflux Disease (GERD) is a major factor driving reflux testing products market revenue growth

Vancouver, Dec. 18, 2023 (GLOBE NEWSWIRE) — The global reflux testing products market size was USD 3.04 Billion in 2022 and is expected to register a revenue CAGR of 4.1% during the forecast period, according to the latest analysis by Emergen Research. Rising prevalence of Gastroesophageal Reflux Disease (GERD), technological advancements in diagnostics, and increasing initiatives and product launches by leading companies are some of the major factors driving the market revenue growth. In addition, rising demand for minimally invasive techniques is also contributing to the market revenue growth.

Rising prevalence of Gastroesophageal Reflux Disease (GERD) is a major factor driving revenue growth of the market. Gastrointestinal disorders affect about 20% of individuals in Western culture and are characterized by regurgitation of gastric contents into the esophagus. As a result, this frequent ailment among the target group is predicted to raise disease awareness, leading to treatment and diagnosis. As a result, it is likely to drive market revenue growth during the forecast period. In addition, increasing initiatives and product launches by leading companies are also driving market revenue growth.

On the other hand, federal government agencies have also started giving product approvals, which is driving revenue growth of the market. For instance, on 21 July 2020, Ironwood Pharmaceuticals, Inc., a leading Gastrointestinal (GI)-focused healthcare company, announced that it has reached an agreement with the U.S. Food and Drug Administration (FDA) on certain updates to its Phase III clinical program evaluating IW-3718 in adults with refractory Gastroesophageal Reflux Disease (GERD).

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/2114

However, high cost of reflux testing products and procedures is restraining revenue growth of the market. Furthermore, reimbursement issues in healthcare can also restrain the reflux testing products market revenue growth as it involves a varied group of healthcare stakeholders, the medical billing process can be complex for certain providers, and each step towards payment is dependent on the previous involvement. Without a clinical trial, many patients can be prescribed FDA-approved therapies despite a lack of significant benefits. Such poor therapies are frequently compensated for by third-party payers.

Scope of Research

Report DetailsOutcome
Market size in 2022USD 3.04 Billion
CAGR (2023–2032)4.1%
Revenue forecast to 2032USD 4.56 Billion
Base year for estimation2022
Historical data2019–2021
Forecast period2023–2032
Quantitative unitsRevenue in USD Billion and CAGR in % from 2023 to 2032
Report coverageRevenue forecast, company ranking, competitive landscape, growth factors, and trends
Segments coveredProduct type, disease indication, end-use, and region
Regional scopeNorth America, Europe, Asia Pacific, Latin America, Middle East & Africa
Country scopeU.S., Canada, Mexico, Germany, France, U.K., Italy, Spain, Benelux, Rest of Europe, China, India, Japan, South Korea, Rest of APAC, Brazil, Rest of LATAM, Saudi Arabia, UAE, South Africa, Turkey, Rest of MEA
Key companies profiledPhathom Pharmaceuticals., Sierra Scientific Instruments, Medtronic, Respiratory Technology Corporation, Alba Diagnostics Ltd, PENTAX Medical, Mui Scientific, Medovation Inc.
Customization scope10 hours of free customization and expert consultation

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/2114

Major Companies and Competitive Landscape

The global reflux testing products market is fairly fragmented with many large and medium-sized players accounting for the majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective reflux testing products. Some major players included in the global reflux testing products market report are:

    • Phathom Pharmaceuticals.
    • Sierra Scientific Instruments
    • Medtronic
    • Respiratory Technology Corporation
    • Alba Diagnostics Ltd
    • PENTAX Medical
    • Mui Scientific
    • Medovation Inc.

Strategic Development

  • On 3 April 2023, Laborie Medical Technologies (Laborie) launched the alpHaONE wireless pH-capsule reflux testing device, a diagnostic and therapeutic healthcare technology firm. The alpHaONE system is designed to diagnose Gastroesophageal Reflux Disease (GERD). This technology can provide up to 96 hours for collecting data and intends to enhance the company’s gastrointestinal motility and reflux portfolio.
  • On 5 June 2023, Lucid Diagnostics Inc., a majority-owned subsidiary of PAVmed Inc. and a commercial-stage cancer prevention diagnostics company, announced the introduction of its first EsoGuard. Florida Digestive Health Associates in Sarasota, Florida, presented the first esophageal precancer screening event using an EsoGuard mobile test device.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/2114

Some Key Highlights From the Report

  • The hospitals and clinics segment accounted for a significantly large revenue share during the forecast period. Factors such as the rise of cancer specialty hospitals decreased treatment costs, and rising gastrointestinal incidences globally are driving revenue growth of this segment. Services for both serious and complex diseases are always available. Hospitals and laboratories conduct Research and Development (R&D) operations to improve therapeutic efficiency while also efficiently meeting the demands of an individual’s health; they focus limited resources within well-designed referral networks.
  • The pH monitoring systems registered a significantly fast revenue growth rate in 2022. The wireless pH monitoring gadget enables 48 hours of continuous monitoring. One advantage of a wireless system is the absence of the trans-nasal catheter, which results in less interference with the patient’s daily activities and higher patient satisfaction.
  • The reflux testing products market in North America accounted for largest revenue share in 2022 owing to the presence of healthcare and hospitality facilities, rising product launches, and their partnerships with leading companies, which is driving revenue growth of the market in this region. For instance, on 8 January 2023, Phathom Pharmaceuticals, Inc., a biopharmaceutical company focused on development and commercialization of novel treatments for gastrointestinal diseases and disorders, announced positive topline outcomes from PHALCON-NERD-301, a Phase 3 study assessing the safety and effectiveness of vonoprazan for the daily treatment of adults with symptomatic Non-Erosive Gastroesophageal Reflux Disease (sGERD or NERD).

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/reflux-testing-products-market

Emergen Research has segmented the global reflux testing products market on the basis of product type, disease indication, end-use, and region:

  • Product Type Outlook (Revenue, USD Billion; 2019-2032)
    • pH Monitoring Systems
      1. Catheter-based testing products
      2. Reflux Testing Probes
      3. Others
    • Capsule Based testing products
    • Impedance Testing Systems
  • Disease Indication Outlook (Revenue, USD Billion; 2019-2032)
    • Diagnosis of GERD
    • Barrett’s esophagus
    • Reflux esophagitis
    • Others
  • End-Use Outlook (Revenue, USD Billion; 2019-2032)
    • Hospitals and Clinics
    • Ambulatory Surgery Centers
    • Specialty Clinics
  • Regional Outlook (Revenue, USD Billion; 2019-2032)
    • North America
      1. U.S.
      2. Canada
      3. Mexico
    • Europe
      1. Germany
      2. France
      3. U.K.
      4. Benelux
      5. Rest of Europe
    • Asia Pacific
      1. China
      2. India
      3. Japan
      4. South Korea
      5. Rest of APAC
    • Latin America
      1. Brazil
      2. Rest of LATAM
    • Middle East & Africa
      1. Saudi Arabia
      2. UAE
      3. Rest of MEA

Curated Reports You Shouldn’t Miss: Dive In Now!

Sleep Apnea Devices Market By Type (Therapeutic Devices and Diagnostic Devices), By End-Use (Sleep Laboratories & Hospitals and Home Care Settings/Individuals), and By Region Forecast to 2030

Veterinary Care Market, By Type (Cow, Dog, Others), By Type of Care (Companion Animal, Production Animal, Others), By Region Forecast to 2032

Therapeutic Drug Monitoring Market By Product (Consumables, Equipment), By Technology (Immunoassays, Chromatography-MS), By Class of Drugs (Antibiotics, Anti-Epileptic Drugs), By End-use, and By Region Forecast to 2030

Ultrasound Market By System Portability (Trolley/Cart-based devices), By Technology (Diagnostic Ultrasound, Therapeutic Ultrasound), By Display Type, By Application, By Component, By End-use, and By Region Forecast to 2030

Artificial Tendons and Ligaments Market, By Applications (Knee injuries, Shoulder injuries, Others), By End-use (Hospitals, Table Top Vending Machine and Others), and By Region Forecast to 2032

Autotransfusion Systems Market By Product (Autotransfusion Products, Autotransfusion Accessories), By Application (Cardiac Surgeries, Orthopedic Surgeries, Organ Transplantation), By End-Use, and By Region Forecast to 2032

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Reflux Testing Products Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-reflux-testing-products-market

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.